Global Antinuclear Antibody Test Market is poised to reach USD 1.48 billion by 2021
©
The Global Antinuclear Antibody Test Market was worth USD 823.50 million in 2016 and expected to reach USD 1.48 billion by 2021 at a CAGR of 12.40%. The market is showcasing evident potential in the mentioned forecasting period. The antinuclear antibody test is a primary test to check a person’s autoimmune disorders. Autoimmune disorders can affect many tissues and organs in the body. This test is most often used to diagnose the Systemic Lupus Erythematous (SLE) and Rheumatoid Arthritis.
Browse Full Report @ http://www.marketdataforecast.com/market-reports/antinuclear-antibody-test-market-3300/
Factors such as increase in prevalence of autoimmune diseases, such as rheumatoid arthritis and SLE, and growth in the awareness of people about these diseases, are driving this market. Autoimmune diseases can also cause type I diabetes. According to WHO, from 1980 to 2014 number of people suffering from diabetes has increased from 108 million to 422 million and is expected to grow at the same rate in near future. Other factors such as, increase in healthcare expenditure of people due to growing economies, and government healthcare insurance & reimbursement policies are fuelling this market. On the other hand, factors such as diagnostic errors, product approval, and unavailability of skilled labour are hindering the growth of this market.
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/antinuclear-antibody-test-market-3300/request-sample
Avail Discount @ http://www.marketdataforecast.com/market-reports/antinuclear-antibody-test-market-3300/request-discount
Global Antinuclear Antibody Test Market Segmentation:
Disease
Technique
Product
End-User
Geographically, market is segmented into
North America,
Latin America,
Europe,
Middle East and Africa,
Asia-Pacific.
Of all these regions, North America has the biggest market share mainly because of growing population and healthcare spending, and growth of people under medical insurances in the U.S. Asia-Pacific is growing at the fastest rate in this market in terms of CAGR.
Some of the major companies dominating the market, by their products and services include Zeus Scientific Inc., Inova Diagnostics, Immuno Concepts, Euroimmun AG, Antibodies Inc., Thermo Fisher Scientific inc., Trinity Biotech plc, ERBA Diagnostics Inc., Bio-Rad Laboratories Inc., and Alere Inc.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Browse Full Report @ http://www.marketdataforecast.com/market-reports/antinuclear-antibody-test-market-3300/
Factors such as increase in prevalence of autoimmune diseases, such as rheumatoid arthritis and SLE, and growth in the awareness of people about these diseases, are driving this market. Autoimmune diseases can also cause type I diabetes. According to WHO, from 1980 to 2014 number of people suffering from diabetes has increased from 108 million to 422 million and is expected to grow at the same rate in near future. Other factors such as, increase in healthcare expenditure of people due to growing economies, and government healthcare insurance & reimbursement policies are fuelling this market. On the other hand, factors such as diagnostic errors, product approval, and unavailability of skilled labour are hindering the growth of this market.
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/antinuclear-antibody-test-market-3300/request-sample
Avail Discount @ http://www.marketdataforecast.com/market-reports/antinuclear-antibody-test-market-3300/request-discount
Global Antinuclear Antibody Test Market Segmentation:
Disease
Technique
Product
End-User
Geographically, market is segmented into
North America,
Latin America,
Europe,
Middle East and Africa,
Asia-Pacific.
Of all these regions, North America has the biggest market share mainly because of growing population and healthcare spending, and growth of people under medical insurances in the U.S. Asia-Pacific is growing at the fastest rate in this market in terms of CAGR.
Some of the major companies dominating the market, by their products and services include Zeus Scientific Inc., Inova Diagnostics, Immuno Concepts, Euroimmun AG, Antibodies Inc., Thermo Fisher Scientific inc., Trinity Biotech plc, ERBA Diagnostics Inc., Bio-Rad Laboratories Inc., and Alere Inc.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases